Buparlisib (BKM120)
Buparlisib is an inhibitor of the pan class I phosphatidylinositol 3-kinase (PI3K) family of lipid kinases with potential antitumor activity. Buparlisib specifically inhibits class I PIK3 in the PI3K/AKT kinase signaling pathway in an ATP-competitive manner, thereby inhibiting the production and activation of the second messenger phosphatidylinositol-3,4,5-trisphosphate and the PI3K signaling pathway.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0129 |
| Pricing | 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire |